Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the therapeutic landscape
GLP-1 receptor agonists, such as liraglutide and semaglutide, have become important drugs for the treatment of type 2 diabetes based on the physiological actions of GLP-1
Antioxidant support Glutathione helps your body fight off free radicals that cause long-term cellular damage
Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
US$ 25.51
US$ 21.00
US$ 29.64
US$ 24.24
US$ 28.06
US$ 21.70
US$ 20.35
US$ 23.07
US$ 23.04
US$ 23.80
